NCT05979207 Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum Status COMPLETED Phase PHASE1
NCT05978037 A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines Status COMPLETED Phase PHASE1/PHASE2
NCT05946642 Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina Faso Status UNKNOWN Phase PHASE3
NCT05930782 Piperaquine Granule Formulation Relative Bioavailability and Food Effect Study in Healthy Volunteers. Status COMPLETED Phase PHASE1
NCT05913973 Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults Status COMPLETED Phase PHASE1
NCT05891236 Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults Status COMPLETED Phase PHASE1
NCT05889052 Perennial Malaria Chemoprevention (PMC) in Cameroon Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05878366 Understanding and Maximizing the Community Impact of Antimalarial Treatment (INDIE-SMC) Status COMPLETED Phase NA
NCT05874869 Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in Tanzania Status COMPLETED Phase NA
NCT05856357 Perennial Malaria Chemoprevention (PMC) in Côte D'Ivoire Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05796193 Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'Ivoire Status ACTIVE_NOT_RECRUITING Phase NA
NCT05690841 FocaL Mass Drug Administration for Vivax Malaria Elimination Status RECRUITING Phase PHASE3